“It’s Been a Bust,” Says Jim Cramer About StubHub (STUB)
We recently published 10 Stocks Jim Cramer Talked About & Revealed Why He’s Critical Of OpenAI. StubHub Holdings, Inc.
Insider Monkey Blog
Applied Materials (AMAT) Was Disappointing, Says Jim Cramer
We recently published 10 Stocks Jim Cramer Talked About & Revealed Why He’s Critical Of OpenAI.
“What is This Company?” Wonders Jim Cramer About Bitdeer (BTDR)
We recently published 10 Stocks Jim Cramer Talked About & Revealed Why He’s Critical Of OpenAI.
Jim Cramer’s Must Read Comments About Oracle (ORCL) & OpenAI
Oracle Corporation (NYSE:ORCL) is one of the biggest enterprise resource planning and AI infrastructure providers in the world.
Jim Cramer Discusses NVIDIA (NVDA) Ahead Of Earnings
We recently published 10 Stocks Jim Cramer Talked About & Revealed Why He’s Critical Of OpenAI.
CoreWeave (CRWV) CEO’s Comments Were “Jarring,” Says Jim Cramer
CoreWeave, Inc. (NASDAQ:CRWV)’s shares are up by 93% since their IPO in March but are down 44% over the past month.
Alphabet (GOOGL)’s a Serious Company “That You Want to Buy,” Says Jim Cramer
Jim Cramer has turned increasingly positive on Alphabet Inc. (NASDAQ:GOOGL) as the year nears its end.
I’ll Feel Great About Walmart (WMT)’s New CEO When I Meet Him, Says Jim Cramer
Cramer spent quite some time discussing Walmart Inc. (NYSE:WMT) after the firm’s announcement that its CEO Doug McMillon would retire and be replaced by John Furner.
Costco (COST)’s A Big Position in My Trust, Says Jim Cramer
We recently published 10 Stocks Jim Cramer Talked About & Revealed Why He’s Critical Of OpenAI.
Why These Energy Stocks are Gaining This Week
The energy sector received a major boost from the sharp uptick in natural gas prices, which are now hovering at their highest level since December 2022 on the back of record LNG...
Eightcap Returns with a Market-First for Prop Traders: Customisable Day Trader Challenges
Eightcap is back in the prop space with a new product that allows traders to choose their timeframe, stake, and reward multiplier. This is in addition to the relaunch of Phase...
10 AI Stocks Investors Are Watching
Wall Street has recently been reacting to concerns about inflation and mixed views from bankers about the health of the US economy.
Jim Cramer’s Thoughts on These 17 Stocks
“Every day at 9:30 AM, I'm listening to my partner Carl Quintanilla announce the names of the companies that are coming public on that particular day.
Jim Cramer Laid Out This Week’s Game Plan: 12 Stocks in Focus
Jim Cramer, the host of Mad Money, said Friday that with a new round of earnings reports on the horizon, the market can sometimes get “so darned ugly” that investors have ...
15 Best 52-Week Low Dividend Stocks to Invest In
Dividend stocks have traditionally attracted long-term investors, but they are often overshadowed by flashy growth stocks in terms of popularity.
RBC Capital Remains Bullish on Viridian Therapeutics (VRDN) Following Q3 2025 Results
On November 6, 2025, RBC Capital raised its price target on Viridian Therapeutics, Inc. (NASDAQ:VRDN) from $41 to $45, while maintaining an “Outperform” rating.
UroGen Pharma (URGN) Closes Q3 2025 With $127.4 Million in Cash Amid Rising R&D Costs
On November 6, 2025, UroGen Pharma Ltd. (NASDAQ:URGN) reported its Q3 2025 results, highlighting strong growth in demand alongside its steady commercial expansion.
Raymond James Remains Bullish on Liquidia (LQDA), Cites YUTREPIA’s 75% Growth in U.S. Prostacyclin Revenue
On November 4, 2025, Raymond James raised its price target on Liquidia Corporation (NASDAQ:LQDA) from $41 to $47, while reiterating a “Strong Buy” rating.
Edgewise Therapeutics (EWTX) Reports Heightened R&D Activity in Q3 2025
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) reported its Q3 2025 results on November 6, 2025.
BMO Capital Remains Bullish on Structure Therapeutics (GPCR), Cites Upcoming Trial Readouts
On November 10, 2025, BMO Capital reiterated its “Outperform” rating on Structure Therapeutics Inc. (NASDAQ:GPCR), setting a $100 price target.
H.C. Wainwright Maintains Its Bullish Stance on Vera Therapeutics (VERA), Sees Strong Future Revenue Growth
On November 10, 2025, The Fly reported that H.C. Wainwright increased its price target on Vera Therapeutics, Inc.
Jones Trading Remains Bullish on Janux Therapeutics (JANX) Amid Promising Developments in Prostate Cancer Program
On November 11, 2025, Jones Trading’s Soumit Roy reiterated his “Buy” rating on Janux Therapeutics, Inc.
Jefferies Maintains “Buy” Rating on Wave Life Sciences (WVE) Amid Its Improving Competitive Positioning
On November 13, 2025, Jefferies analyst Roger Song noted that Wave Life Sciences Ltd.
William Blair Maintains Bullish Stance on Biohaven (BHVN), Sees Robust Operational Growth
On November 11, 2025, William Blair kept its “Market Perform” rating.
JPMorgan Reduces PT on Syndax Pharmaceuticals (SNDX) to $33, Maintains “Overweight” Rating
On November 12, 2025, Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) saw JPMorgan reduce its price target from $40 to $33, while reiterating its “Overweight” rating.
Sealed Air (SEE) Climbs 18% on Takeover Bid
Sealed Air saw its share prices jump by 18.09 percent week-on-week as investor sentiment was fueled by reports that it is set to be acquired by investment firm Clayton, Dubilier...
Clearwater (CWAN) Jumps 19% as Firms Eye Takeover
We recently published 10 Market Movers That Made Millionaires in a Week. Clearwater Analytics Holdings Inc.
On Holding (ONON) Surges 21% on Earnings Blowout, Upbeat Outlook
On Holding grew its share prices by 21.14 percent week-on-week as investor sentiment was boosted by a stellar earnings performance that sparked a higher growth outlook for the...
Ondas Holdings (ONDS) Climbs 23% on Bullish Outlook, Q3 Blowout
Ondas Holdings soared by 23.58 percent week-on-week as investors took heart from an investment firm’s bullish outlook for the stock, while also cheering its stellar earnings...
Opendoor (OPEN) Soars 24% Ahead of Dividends
We recently published 10 Market Movers That Made Millionaires in a Week. Opendoor Technologies Inc.
Baytex (BTE) Climbs 25%, Extends 8-Day Run on Bullish Rating
Baytex Energy jumped by 25.4 percent week-on-week after an eight-day rally boosted by an investment firm’s bullish rating and news that it was officially exiting the US market...
Avadel (AVDL) Gets 26% Boost on Takeover Bid
We recently published 10 Market Movers That Made Millionaires in a Week.
Scholar Rock (SRRK) Soars 29% as Drug Candidate Progresses
We recently published 10 Market Movers That Made Millionaires in a Week. Scholar Rock Holding Corp.
Cidara (CDTX) Climbs 105% on $9.2-Billion Merger with Merck
Cidara Therapeutics soared by more than 100 percent week-on-week, as investors repositioned portfolios following news that it is set to be acquired by Merck Co.
Cogent Biosciences (COGT) Soars 126% on Stomach Cancer Treatment Progress
Cogent Biosciences skyrocketed by 126.3 percent week-on-week, as investor sentiment was boosted by the promising results of its last clinical trial that tested the efficacy of...
11 Overlooked Tech Stocks to Invest In
The past week, ending November 7, saw U.S. artificial intelligence-related stocks retreat amid mounting valuation concerns.
10 Market Movers That Made Millionaires in a Week
Ten companies skyrocketed last week, jumping by double and triple digits, as investor sentiment was fueled by a flurry of corporate developments, strong earnings performance, ...
Costco’s (COST) Been A Disappointment but I’d Never Sell It, Says Jim Cramer
We recently published 9 Stocks Jim Cramer Talked About in a Show Where He Advised OpenAI to Slow Down.
Lam Research’s (LRCX) Going to “Have Orders as Far as the Eye Can See,” Says Jim Cramer
We recently published 9 Stocks Jim Cramer Talked About in a Show Where He Advised OpenAI to Slow Down.
Poorly Run CarMax (KMX) “Misjudged” The Market, Says Jim Cramer
We recently published 9 Stocks Jim Cramer Talked About in a Show Where He Advised OpenAI to Slow Down. CarMax, Inc.
Intuit’s (INTU) Brand New Program Hasn’t Done Anything for the Stock, Says Jim Cramer
We recently published 9 Stocks Jim Cramer Talked About in a Show Where He Advised OpenAI to Slow Down. Intuit Inc.
Moving iMage Technologies, Inc. (AMEX:MITQ) Q1 2026 Earnings Call Transcript
Operator: Greetings. Welcome to Moving iMage Technologies, First Quarter 2026 Earnings Call. [Operator Instructions] Please note the conference is being recorded.
Koil Energy Solutions, Inc. (OTC:KLNG) Q3 2025 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. Thank you for standing by. Welcome to the Koil Energy Third Quarter 2025 Earnings Conference Call.
Nortech Systems Incorporated (NASDAQ:NSYS) Q3 2025 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Nortex Systems Incorporated Third Quarter twenty twenty five Earnings Conference Call.
16 Latest Stocks on Jim Cramer’s Radar
In his latest appearance on CNBC's Squawk on the Street, Jim Cramer discussed trends in how wealthy Americans were spending their money and mentioned The Wall Street Journal's...
“FedEx (FDX) is the Economy,” Says Jim Cramer
We recently published 9 Stocks Jim Cramer Talked About in a Show Where He Advised OpenAI to Slow Down.
Everyone Should Watch Capital One (COF), Says Jim Cramer
We recently published 9 Stocks Jim Cramer Talked About in a Show Where He Advised OpenAI to Slow Down.
Block’s (XYZ) “Not That Great,” Says Jim Cramer
We recently published 9 Stocks Jim Cramer Talked About in a Show Where He Advised OpenAI to Slow Down. Block, Inc.
PayPal (PYPL) Having A Good CEO Hasn’t Meant Much, Says Jim Cramer
We recently published 9 Stocks Jim Cramer Talked About in a Show Where He Advised OpenAI to Slow Down. PayPal Holdings, Inc.
Hedge Fund Resource Center
